数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
George Paz Chairman 61 1191.68万美元 未持股 2017-03-17
Timothy Wentworth Director, President and Chief Executive Officer 56 1452.22万美元 未持股 2017-03-17
Elder Granger Director 63 28.90万美元 未持股 2017-03-17
Woodrow A. Myers, Jr. Director 63 30.30万美元 未持股 2017-03-17
Maura C. Breen Director 61 30.85万美元 未持股 2017-03-17
Thomas P. Mac Mahon Director 70 34.53万美元 未持股 2017-03-17
Frank Mergenthaler Director 56 31.45万美元 未持股 2017-03-17
Seymour Sternberg Director 73 30.40万美元 未持股 2017-03-17
William L. Roper Director 68 28.63万美元 未持股 2017-03-17
William J. DeLaney Director 61 30.60万美元 未持股 2017-03-17
Nicholas J. LaHowchic Director 70 30.60万美元 未持股 2017-03-17
Roderick A. Palmore Director 65 28.90万美元 未持股 2017-03-17

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Timothy Wentworth Director, President and Chief Executive Officer 56 1452.22万美元 未持股 2017-03-17
Neal Sample Senior Vice President and Chief Information Officer 49 438.40万美元 未持股 2017-03-17
David Queller Senior Vice President, Sales and Account Management 55 336.01万美元 未持股 2017-03-17
Eric Slusser Executive Vice President and Chief Financial Officer 63 451.75万美元 未持股 2017-03-17
Martin Akins Senior Vice President, General Counsel and Corporate Secretary 57 未披露 未持股 2017-03-17
Phyllis Anderson Senior Vice President and Chief Marketing Officer 64 未披露 未持股 2017-03-17
Christopher McGinnis Vice President, Chief Accounting Officer and Corporate Controller 52 未披露 未持股 2017-03-17
Everett Neville Senior Vice President, Supply Chain & Specialty 59 未披露 未持股 2017-03-17
Christine Houston Executive Vice President and Chief Operations Officer 61 344.11万美元 未持股 2017-03-17
Steven Miller -- Senior Vice President and Chief Medical Officer 66 未披露 未持股 2017-03-17
Glen Stettin Senior Vice President, Clinical Research and New Solutions and Chief Innovation Officer 60 未披露 未持股 2017-03-17
Sara Wade Senior Vice President and Chief Human Resources Officer 54 351.87万美元 未持股 2017-03-17

董事简历

中英对照 |  中文 |  英文
George Paz

George Paz,自2006年5月和2005年4月起分别担任Express Scripts Holding Company Express Scripts(处方管理公司)的董事长和首席执行官。他将于2016年5月辞去首席执行官一职,但仍将担任董事长。他于2003年10月至2014年2月间担任Express Scripts的总裁;1998年加入Express Scripts担任高级副总裁兼首席财务官。在加入Express Scripts之前,他于1988年至1993年和1996年至1998年间担任Coopers and Lybrand的合伙人,1993年至1995年间担任Life Partners Group的执行副总裁兼首席财务官。


George Paz was Non-Executive Chairman of Express Scripts Holding Company Express Scripts, a prescription benefit management company, from May 2016 to December 2018 and served as Chairman and CEO of Express Scripts from May 2006 to May 2016 after being appointed CEO in April 2005. Prior to joining Express Scripts, Mr. Paz was a partner at Coopers and Lybrand from 1988 to 1993 and 1996 to 1998 and served as EVP and CFO for Life Partners Group from 1993 to 1995. Express Scripts Holding Company(December 2018).Honeywell International, Inc.
George Paz,自2006年5月和2005年4月起分别担任Express Scripts Holding Company Express Scripts(处方管理公司)的董事长和首席执行官。他将于2016年5月辞去首席执行官一职,但仍将担任董事长。他于2003年10月至2014年2月间担任Express Scripts的总裁;1998年加入Express Scripts担任高级副总裁兼首席财务官。在加入Express Scripts之前,他于1988年至1993年和1996年至1998年间担任Coopers and Lybrand的合伙人,1993年至1995年间担任Life Partners Group的执行副总裁兼首席财务官。
George Paz was Non-Executive Chairman of Express Scripts Holding Company Express Scripts, a prescription benefit management company, from May 2016 to December 2018 and served as Chairman and CEO of Express Scripts from May 2006 to May 2016 after being appointed CEO in April 2005. Prior to joining Express Scripts, Mr. Paz was a partner at Coopers and Lybrand from 1988 to 1993 and 1996 to 1998 and served as EVP and CFO for Life Partners Group from 1993 to 1995. Express Scripts Holding Company(December 2018).Honeywell International, Inc.
Timothy Wentworth

Timothy Wentworth , 2014年2月被任命为公司总裁。从2012年4月到2014年2月,担任销售与客户管理部门高级副总裁。2012年4月快捷药方公司与美可保健公司合并,他于此时加入快捷药方公司。在美可保健公司,他从2008年10月到2012年4月担任全国重要客户集团总裁;2006年3月到2008年10月担任美可保健的附属子公司Accredo健康集团首席执行光;2003年8月到2006年3月担任全国客户集团总裁。


Timothy Wentworth was elected a director of Express Scripts in June 2015. He was elected President of the Company in February 2014 and assumed the role of Chief Executive Officer on May 4 2016. Mr. Wentworth previously served as Senior Vice President and President, Sales and Account Management from April 2012 to February 2014. Mr. Wentworth joined Express Scripts when the Company merged with Medco in April 2012. At Medco, he served as Group President, National and Key Accounts from October 2008 to April 2012 as Chief Executive Officer of Medco’s Accredo Health Group subsidiary from March 2006 to October 2008 and as Group President-National Accounts from August 2003 to March 2006.
Timothy Wentworth , 2014年2月被任命为公司总裁。从2012年4月到2014年2月,担任销售与客户管理部门高级副总裁。2012年4月快捷药方公司与美可保健公司合并,他于此时加入快捷药方公司。在美可保健公司,他从2008年10月到2012年4月担任全国重要客户集团总裁;2006年3月到2008年10月担任美可保健的附属子公司Accredo健康集团首席执行光;2003年8月到2006年3月担任全国客户集团总裁。
Timothy Wentworth was elected a director of Express Scripts in June 2015. He was elected President of the Company in February 2014 and assumed the role of Chief Executive Officer on May 4 2016. Mr. Wentworth previously served as Senior Vice President and President, Sales and Account Management from April 2012 to February 2014. Mr. Wentworth joined Express Scripts when the Company merged with Medco in April 2012. At Medco, he served as Group President, National and Key Accounts from October 2008 to April 2012 as Chief Executive Officer of Medco’s Accredo Health Group subsidiary from March 2006 to October 2008 and as Group President-National Accounts from August 2003 to March 2006.
Elder Granger

Elder Granger于2014年11月当选为董事会成员。Granger博士是退休的美国陆军少将,以及5Ps LLC的总裁兼首席执行官。 Granger博士此前从2011年10月起担任DLH的战略顾问委员会顾问,直至当选为董事会成员。Granger博士在美国陆军服役超过35年,并于2005年至2009年担任华盛顿特区负责国防部长(卫生事务)办公室TRICARE管理活动的副主任和项目执行官。他曾担任助理国防部长(卫生事务)的国防部健康计划,政策和绩效的首席顾问。监督了军队卫生系统内国防部管理式医疗计划的收购,运营和整合。加盟TRICARE管理活动,Granger博士领导的美国和最大的跨国战场卫生系统,同时服务于指挥官,特遣部队第44医务司令部和司令部医生为多国部队伊拉克。目前,Granger博士是The 5Ps,LLC的总裁兼首席执行官,该医疗保健,教育和领导咨询公司是在他从美国军队退休后成立的。格兰杰博士获得了阿肯色州立大学的学士学位,并获得了阿肯色大学医学院的医学学位。从阿肯色大学医学院毕业后,他被授予Henry Kaiser医疗卓越和领导力医疗奖学金。 Granger博士获得了美国医师管理学院,美国医学质量委员会,美国内科医学委员会,肿瘤内科,血液学委员会的认证,并拥有多项医学证书。公司董事的全国协会,研究员,Granger目前担任Express Scripts的控股有限公司的董事会(成员 - 遵约委员会),并还额外privately-的董事会的现任和前任顾问或成员举办公司。Granger博士还是罗莎琳德富兰克林医学和科学大学董事会成员以及阿肯色大学医学院访客委员会成员。


Elder Granger,was elected to Dlh Holdings Corp. Board of Directors in November 2014. Dr. Granger is a U.S. Army Major General (retired) and the President and Chief Executive Officer of The 5Ps LLC. Dr. Granger previously served as an advisor to DLH on its strategic advisory board from October 2011 until his election to the Board. Dr. Granger served in the U.S. Army for over 35 years and was the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, D.C. from 2005 to 2009. In this role he served as the principal advisor to the Assistant Secretary of Defense (Health Affairs) on DoD health plan, policy and performance. He oversaw the acquisition, operation and integration of DoD's managed care program within the Military Health System. Prior to joining TRICARE Management Activity, Dr. Granger led the largest U.S. and multi-national battlefield health system in Dlh Holdings Corp. recent history while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. Presently, Dr. Granger is the President and CEO of The 5Ps, LLC, a healthcare, education, and leadership consultancy he founded following his retirement from the U.S. Army. Dr. Granger received a B.S. Degree from Arkansas State University and earned his medical degree from University of Arkansas School of Medicine. Upon graduation from the University of Arkansas School of Medicine, he was awarded the Henry Kaiser Medical Fellowship for Medical Excellence and Leadership. Dr. Granger is board certified by the American College of Physician Executives, American Board of Medical Quality, American Board of Internal Medicine, Medical Oncology, Hematology, and holds numerous medical certifications. Additionally, Dr. Granger has earned the CERT Certificate in Cybersecurity Oversight from Carnegie Mellon University. A National Association of Corporate Director, Certified Director and Fellow, Dr. Granger currently serves on the board of directors of Cigna Corp., since December 2018 (chair – Compliance Committee and member – Corporate Governance Committee), and Better Therapeutics, Inc. since 2021 (member – Audit Committee). He served on the board of Express Scripts Holding from 2015 until its merger with Cigna Corp. and served on the board of Cerner Corp. from November 2020 to June 2022 (member – Audit Committee and Nominating, Governance and Public Policy Committee). Dr. Granger is also a current and former advisor or member of the board of directors of additional privately-held companies and also serves on the Board of Visitors of the University of Arkansas School of Medicine.
Elder Granger于2014年11月当选为董事会成员。Granger博士是退休的美国陆军少将,以及5Ps LLC的总裁兼首席执行官。 Granger博士此前从2011年10月起担任DLH的战略顾问委员会顾问,直至当选为董事会成员。Granger博士在美国陆军服役超过35年,并于2005年至2009年担任华盛顿特区负责国防部长(卫生事务)办公室TRICARE管理活动的副主任和项目执行官。他曾担任助理国防部长(卫生事务)的国防部健康计划,政策和绩效的首席顾问。监督了军队卫生系统内国防部管理式医疗计划的收购,运营和整合。加盟TRICARE管理活动,Granger博士领导的美国和最大的跨国战场卫生系统,同时服务于指挥官,特遣部队第44医务司令部和司令部医生为多国部队伊拉克。目前,Granger博士是The 5Ps,LLC的总裁兼首席执行官,该医疗保健,教育和领导咨询公司是在他从美国军队退休后成立的。格兰杰博士获得了阿肯色州立大学的学士学位,并获得了阿肯色大学医学院的医学学位。从阿肯色大学医学院毕业后,他被授予Henry Kaiser医疗卓越和领导力医疗奖学金。 Granger博士获得了美国医师管理学院,美国医学质量委员会,美国内科医学委员会,肿瘤内科,血液学委员会的认证,并拥有多项医学证书。公司董事的全国协会,研究员,Granger目前担任Express Scripts的控股有限公司的董事会(成员 - 遵约委员会),并还额外privately-的董事会的现任和前任顾问或成员举办公司。Granger博士还是罗莎琳德富兰克林医学和科学大学董事会成员以及阿肯色大学医学院访客委员会成员。
Elder Granger,was elected to Dlh Holdings Corp. Board of Directors in November 2014. Dr. Granger is a U.S. Army Major General (retired) and the President and Chief Executive Officer of The 5Ps LLC. Dr. Granger previously served as an advisor to DLH on its strategic advisory board from October 2011 until his election to the Board. Dr. Granger served in the U.S. Army for over 35 years and was the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, D.C. from 2005 to 2009. In this role he served as the principal advisor to the Assistant Secretary of Defense (Health Affairs) on DoD health plan, policy and performance. He oversaw the acquisition, operation and integration of DoD's managed care program within the Military Health System. Prior to joining TRICARE Management Activity, Dr. Granger led the largest U.S. and multi-national battlefield health system in Dlh Holdings Corp. recent history while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. Presently, Dr. Granger is the President and CEO of The 5Ps, LLC, a healthcare, education, and leadership consultancy he founded following his retirement from the U.S. Army. Dr. Granger received a B.S. Degree from Arkansas State University and earned his medical degree from University of Arkansas School of Medicine. Upon graduation from the University of Arkansas School of Medicine, he was awarded the Henry Kaiser Medical Fellowship for Medical Excellence and Leadership. Dr. Granger is board certified by the American College of Physician Executives, American Board of Medical Quality, American Board of Internal Medicine, Medical Oncology, Hematology, and holds numerous medical certifications. Additionally, Dr. Granger has earned the CERT Certificate in Cybersecurity Oversight from Carnegie Mellon University. A National Association of Corporate Director, Certified Director and Fellow, Dr. Granger currently serves on the board of directors of Cigna Corp., since December 2018 (chair – Compliance Committee and member – Corporate Governance Committee), and Better Therapeutics, Inc. since 2021 (member – Audit Committee). He served on the board of Express Scripts Holding from 2015 until its merger with Cigna Corp. and served on the board of Cerner Corp. from November 2020 to June 2022 (member – Audit Committee and Nominating, Governance and Public Policy Committee). Dr. Granger is also a current and former advisor or member of the board of directors of additional privately-held companies and also serves on the Board of Visitors of the University of Arkansas School of Medicine.
Woodrow A. Myers, Jr.

Woodrow A. Myers, Jr.,医学博士,自2021年3月起担任Personalis, Inc.的董事。从2007年5月到2018年12月,Myers博士担任Express Scripts Inc.(一家上市医疗保健公司)的董事会成员。从2018年1月到2019年2月,Myers博士担任亚利桑那州蓝十字蓝盾公司的首席医疗官和首席医疗保健策略师。自2015年12月以来,Myers博士担任Myers Ventures LLC(医疗咨询公司)的董事总经理。Myers博士持有Stanford University的生物学学士学位、Stanford Graduate School of Business的工商管理硕士学位和Harvard Medical School的医学博士学位。


Woodrow A. Myers, Jr., M.D. has served on Personalis, Inc. of Directors since March 2021. From May 2007 to December 2018 Dr. Myers served on the board of directors of Express Scripts Inc., a publicly traded health care company. From January 2018 to February 2019 Dr. Myers served as Chief Medical Officer and Chief Healthcare Strategist for Blue Cross Blue Shield of Arizona. Since December 2015 Dr. Myers has served as Managing Director of Myers Ventures LLC, a healthcare consulting company. Dr. Myers holds a B.S. in Biology from Stanford University, an M.B.A. from Stanford Graduate School of Business, and an M.D. from Harvard Medical School.
Woodrow A. Myers, Jr.,医学博士,自2021年3月起担任Personalis, Inc.的董事。从2007年5月到2018年12月,Myers博士担任Express Scripts Inc.(一家上市医疗保健公司)的董事会成员。从2018年1月到2019年2月,Myers博士担任亚利桑那州蓝十字蓝盾公司的首席医疗官和首席医疗保健策略师。自2015年12月以来,Myers博士担任Myers Ventures LLC(医疗咨询公司)的董事总经理。Myers博士持有Stanford University的生物学学士学位、Stanford Graduate School of Business的工商管理硕士学位和Harvard Medical School的医学博士学位。
Woodrow A. Myers, Jr., M.D. has served on Personalis, Inc. of Directors since March 2021. From May 2007 to December 2018 Dr. Myers served on the board of directors of Express Scripts Inc., a publicly traded health care company. From January 2018 to February 2019 Dr. Myers served as Chief Medical Officer and Chief Healthcare Strategist for Blue Cross Blue Shield of Arizona. Since December 2015 Dr. Myers has served as Managing Director of Myers Ventures LLC, a healthcare consulting company. Dr. Myers holds a B.S. in Biology from Stanford University, an M.B.A. from Stanford Graduate School of Business, and an M.D. from Harvard Medical School.
Maura C. Breen

MauraC.Breen于2004年7月被选为Express Scripts的董事。从2006年3月到2008年9月退休,布林女士担任威瑞森通信公司(Verizon Communications,Inc.)纽约地区的高级副总裁兼总经理,该公司是一家通信服务提供商。此前,Breen女士从2003年12月到2006年3月担任Verizon网络服务集团高级副总裁/支持服务。从2001年7月到2003年12月,布林女士还担任威瑞森公司零售市场集团的高级副总裁兼首席营销官。


Maura C. Breen was elected a director of Express Scripts in July 2004. Ms. Breen served as Senior Vice President and General Manager for the New York Region for Verizon Communications, Inc. or “Verizon,” a provider of communications services, from March 2006 until her retirement in September 2008. Previously, Ms. Breen was Senior Vice President/Support Services, Network Services Group for Verizon, from December 2003 through March 2006. Ms. Breen also served as Senior Vice President & Chief Marketing Officer, Retail Market Groups for Verizon from July 2001 through December 2003.
MauraC.Breen于2004年7月被选为Express Scripts的董事。从2006年3月到2008年9月退休,布林女士担任威瑞森通信公司(Verizon Communications,Inc.)纽约地区的高级副总裁兼总经理,该公司是一家通信服务提供商。此前,Breen女士从2003年12月到2006年3月担任Verizon网络服务集团高级副总裁/支持服务。从2001年7月到2003年12月,布林女士还担任威瑞森公司零售市场集团的高级副总裁兼首席营销官。
Maura C. Breen was elected a director of Express Scripts in July 2004. Ms. Breen served as Senior Vice President and General Manager for the New York Region for Verizon Communications, Inc. or “Verizon,” a provider of communications services, from March 2006 until her retirement in September 2008. Previously, Ms. Breen was Senior Vice President/Support Services, Network Services Group for Verizon, from December 2003 through March 2006. Ms. Breen also served as Senior Vice President & Chief Marketing Officer, Retail Market Groups for Verizon from July 2001 through December 2003.
Thomas P. Mac Mahon

Thomas P. Mac Mahon自2007年1月31日担任公司董事。2007年7月31日至2010年12月31日,他担任董事会主席,现是公司薪酬委员会主席。自1995年, Mac Mahon担任美国控股公司LabCorp董事。此外,2007年1月至2009年5月他担任LabCorp董事会非执行主席;1996年4月至2006年12月任董事会执行主席;1995年4月任董事会副主席。1997年1月至2006年12月退休,Mac Mahon在 LabCorp.担任总裁、首席执行官以及行政管理委员会成员。他曾于1993年至1996年12月任罗氏医疗股份有限公司高级副总裁;1988年至1996年12月任罗氏诊断集团总裁兼执行委员会董事和成员。Mac Mahon 现任快捷药方股份有限公司董事及公司治理委员会主席,也是SynapDx公司和Aushon Biosystems股份有限公司董事会成员。


Thomas P. Mac Mahon was elected a director of Express Scripts in March 2001 and has served as Lead Independent Director since May 2008. Thomas P. Mac Mahon has served as a director since July 31 2007 and Chairman of the Compensation Committee since 2012 in addition to serving as Chairman of the Compensation Committee from July 2007 to February 2008. From 1995 to April 2013 Mr. Mac Mahon served as a director of Laboratory Corporation of America Holdings "LabCorp". In addition, Mr. Mac Mahon served as a non-executive Chairman of the Board of LabCorp from January 2007 to May 2009; and Executive Chairman of the Board from April 1996 to December 2006. From January 1997 until his retirement in December, 2006 Mr. Mac Mahon served as President and Chief Executive Officer. Mr. Mac Mahon was Senior Vice President or Hoffmann La Roche, Inc. from 1993 to December 1996 and President of Roche Diagnostics Group and a director and member of the Executive Committee of Hoffmann La Roche from 1988 to December 1996. Mr. Mac Mahon is a director and Corporate Governance Committee Chairperson of Express Scripts, Inc. and is a member of the Board of three private companies, SynapDx Corporation, Aushon BiosyStems, Inc. and Ortho Clinical Diagnostics.
Thomas P. Mac Mahon自2007年1月31日担任公司董事。2007年7月31日至2010年12月31日,他担任董事会主席,现是公司薪酬委员会主席。自1995年, Mac Mahon担任美国控股公司LabCorp董事。此外,2007年1月至2009年5月他担任LabCorp董事会非执行主席;1996年4月至2006年12月任董事会执行主席;1995年4月任董事会副主席。1997年1月至2006年12月退休,Mac Mahon在 LabCorp.担任总裁、首席执行官以及行政管理委员会成员。他曾于1993年至1996年12月任罗氏医疗股份有限公司高级副总裁;1988年至1996年12月任罗氏诊断集团总裁兼执行委员会董事和成员。Mac Mahon 现任快捷药方股份有限公司董事及公司治理委员会主席,也是SynapDx公司和Aushon Biosystems股份有限公司董事会成员。
Thomas P. Mac Mahon was elected a director of Express Scripts in March 2001 and has served as Lead Independent Director since May 2008. Thomas P. Mac Mahon has served as a director since July 31 2007 and Chairman of the Compensation Committee since 2012 in addition to serving as Chairman of the Compensation Committee from July 2007 to February 2008. From 1995 to April 2013 Mr. Mac Mahon served as a director of Laboratory Corporation of America Holdings "LabCorp". In addition, Mr. Mac Mahon served as a non-executive Chairman of the Board of LabCorp from January 2007 to May 2009; and Executive Chairman of the Board from April 1996 to December 2006. From January 1997 until his retirement in December, 2006 Mr. Mac Mahon served as President and Chief Executive Officer. Mr. Mac Mahon was Senior Vice President or Hoffmann La Roche, Inc. from 1993 to December 1996 and President of Roche Diagnostics Group and a director and member of the Executive Committee of Hoffmann La Roche from 1988 to December 1996. Mr. Mac Mahon is a director and Corporate Governance Committee Chairperson of Express Scripts, Inc. and is a member of the Board of three private companies, SynapDx Corporation, Aushon BiosyStems, Inc. and Ortho Clinical Diagnostics.
Frank Mergenthaler

Frank Mergenthaler,2005年8月他受雇担任执行副总裁兼首席财务官。在加入我们之前,从2002年7月到2005年7月他担任Columbia House公司执行副总裁兼首席财务官。从2001年12月到2001年3月,Mergenthaler先生担任维旺迪环球公司的高级副总裁兼副首席财务官。在之前从1996年11月到1996年12月,Mergenthaler先生是施格兰有限公司的一位高管。Mergenthaler先生是Express Scripts公司的董事。


Frank Mergenthaler was hired in August 2005 as Executive Vice President and Chief Financial Officer. Prior to joining us, he served as Executive Vice President and Chief Financial Officer for Columbia House Company from July 2002 to July 2005. Mr. Mergenthaler served as Senior Vice President and Deputy Chief Financial Officer for Vivendi Universal from December 2001 to March 2002. Prior to that time, Mr. Mergenthaler was an executive at Seagram Company Ltd. from November 1996 to December 2001. Mr. Mergenthaler is a director of Express Scripts, Inc.
Frank Mergenthaler,2005年8月他受雇担任执行副总裁兼首席财务官。在加入我们之前,从2002年7月到2005年7月他担任Columbia House公司执行副总裁兼首席财务官。从2001年12月到2001年3月,Mergenthaler先生担任维旺迪环球公司的高级副总裁兼副首席财务官。在之前从1996年11月到1996年12月,Mergenthaler先生是施格兰有限公司的一位高管。Mergenthaler先生是Express Scripts公司的董事。
Frank Mergenthaler was hired in August 2005 as Executive Vice President and Chief Financial Officer. Prior to joining us, he served as Executive Vice President and Chief Financial Officer for Columbia House Company from July 2002 to July 2005. Mr. Mergenthaler served as Senior Vice President and Deputy Chief Financial Officer for Vivendi Universal from December 2001 to March 2002. Prior to that time, Mr. Mergenthaler was an executive at Seagram Company Ltd. from November 1996 to December 2001. Mr. Mergenthaler is a director of Express Scripts, Inc.
Seymour Sternberg

Seymour Sternberg, 自2005年12月以来,他曾担任CIT的董事。1997年4月到2009年6月,他担任纽约人寿保险公司的董事会主席和首席执行官。1989年他加盟纽约人寿担任高级副总裁,担任越来越重要的职务,包括执行副总裁、副董事长、总裁、首席运营官和首席执行官。他是Express Scripts公司的董事会董事,一家药房福利管理商。他是美国对外关系委员会的成员。他目前就职于,或在过去的5年就职于美国商会,纽约长老会医院/哥伦比亚大学医学中心,东北大学哈克利学校,大兄弟/姐妹,纽约市伙伴关系,纽约市领导学院,肯尼迪中心企业基金的董事。


Seymour Sternberg has served as a director of CIT since December 2005. Mr. Sternberg served as Chairman of the Board of Directors & CEO of New York Life Insurance Company from April 1997 until June 2009. Mr. Sternberg joined New York Life as a Senior Vice President in 1989 and held positions of increasing responsibility, including Executive Vice President, Vice Chairman, President, Chief Operating Officer and Chief Executive Officer. Mr. Sternberg serves on the Board of Directors of Express Scripts, Inc., a pharmacy benefits manager. He is a member of the Council on Foreign Relations. Mr. Sternberg currently serves, or during the preceding five years served, on the boards of the U.S. Chamber of Commerce, New York-Presbyterian Hospital/Columbia University Medical Center, Northeastern University, the Hackley School, Big Brothers/Big Sisters, New York City Partnership, the New York City Leadership Academy, and the Kennedy Center Corporate Fund. Mr. Sternberg was appointed by former President Clinton as one of three U.S. representatives to the Business Advisory Council of the Asia-Pacific Economic Cooperation and has also served or serves on the boards of several public or private companies and charitable organizations. Mr. Sternberg served as a director of CIT Group Inc. from December 2005 to May 2016 and is currently a director of Northeastern University.
Seymour Sternberg, 自2005年12月以来,他曾担任CIT的董事。1997年4月到2009年6月,他担任纽约人寿保险公司的董事会主席和首席执行官。1989年他加盟纽约人寿担任高级副总裁,担任越来越重要的职务,包括执行副总裁、副董事长、总裁、首席运营官和首席执行官。他是Express Scripts公司的董事会董事,一家药房福利管理商。他是美国对外关系委员会的成员。他目前就职于,或在过去的5年就职于美国商会,纽约长老会医院/哥伦比亚大学医学中心,东北大学哈克利学校,大兄弟/姐妹,纽约市伙伴关系,纽约市领导学院,肯尼迪中心企业基金的董事。
Seymour Sternberg has served as a director of CIT since December 2005. Mr. Sternberg served as Chairman of the Board of Directors & CEO of New York Life Insurance Company from April 1997 until June 2009. Mr. Sternberg joined New York Life as a Senior Vice President in 1989 and held positions of increasing responsibility, including Executive Vice President, Vice Chairman, President, Chief Operating Officer and Chief Executive Officer. Mr. Sternberg serves on the Board of Directors of Express Scripts, Inc., a pharmacy benefits manager. He is a member of the Council on Foreign Relations. Mr. Sternberg currently serves, or during the preceding five years served, on the boards of the U.S. Chamber of Commerce, New York-Presbyterian Hospital/Columbia University Medical Center, Northeastern University, the Hackley School, Big Brothers/Big Sisters, New York City Partnership, the New York City Leadership Academy, and the Kennedy Center Corporate Fund. Mr. Sternberg was appointed by former President Clinton as one of three U.S. representatives to the Business Advisory Council of the Asia-Pacific Economic Cooperation and has also served or serves on the boards of several public or private companies and charitable organizations. Mr. Sternberg served as a director of CIT Group Inc. from December 2005 to May 2016 and is currently a director of Northeastern University.
William L. Roper

William L. Roper, MD, MPH,2012年4月被正式任命为美国快捷药方公司董事。2007年12月至2012年4月Medco交易完成期间,他曾担任Medco Health Solutions, Inc.董事。2004年起担任北卡罗莱纳大学(UNC)教堂山分校医学院院长和医学事务校长和北卡罗来纳大学卫生保健系统CEO。他还担任了UNC医学院儿科和社会医学教授,以及UNC公共卫生学院卫生政策和行政管理教授。在1997年加入UNC之前,他曾于1993-1997年担任Prudential Health Care高就副总裁和其他职位。1990-1993年他还担任疾病控制和预防中心董事,1989年和1990年担任高级白宫幕僚,1986-1989年担任SMS管理者。2001年起担任DaVita HealthCare Partners Inc.董事。他是国家质量论坛(一家私人非营利公共福利公司,它的建立是为了促进卫生保健质量衡量和报告的标准化)董事会成员及前任董事会主席。


William L. Roper has been one of our directors since May 2001. In January 2019 Dr. Roper became interim president of the University of North Carolina System, North Carolina's system of public higher education. Prior to that, Dr. Roper was chief executive officer of the University of North Carolina “UNC” Health Care System, dean of the UNC School of Medicine and vice chancellor for medical affairs of UNC since March 2004. Dr. Roper has also served on the board of directors of Cigna Corporation, a health services corporation, since December 2018. Dr. Roper also continues to serve as a professor of health policy and administration in the UNC School of Public Health and a professor of pediatrics and of social medicine in the UNC School of Medicine. From 1997 until March 2004 he was dean of the UNC School of Public Health. Before joining UNC in 1997 Dr. Roper served as senior vice president of Prudential Health Care. He also served as director of the Centers for Disease Control and Prevention from 1990 to 1993 on the senior White House staff in 1989 and 1990 and as the administrator of Centers for Medicare & Medicaid Services from 1986 to 1989. Dr. Roper was a member of and is the immediate past chairman of the board of the National Quality Forum, a non-profit organization that aims to improve the quality of healthcare. From December 2007 to November 2011 Dr. Roper served on the board of Medco Health Solutions, Inc., a pharmacy benefits management company, and from November 2011 until December 2018 served on the board of its successor company, Express Scripts Holding Company.
William L. Roper, MD, MPH,2012年4月被正式任命为美国快捷药方公司董事。2007年12月至2012年4月Medco交易完成期间,他曾担任Medco Health Solutions, Inc.董事。2004年起担任北卡罗莱纳大学(UNC)教堂山分校医学院院长和医学事务校长和北卡罗来纳大学卫生保健系统CEO。他还担任了UNC医学院儿科和社会医学教授,以及UNC公共卫生学院卫生政策和行政管理教授。在1997年加入UNC之前,他曾于1993-1997年担任Prudential Health Care高就副总裁和其他职位。1990-1993年他还担任疾病控制和预防中心董事,1989年和1990年担任高级白宫幕僚,1986-1989年担任SMS管理者。2001年起担任DaVita HealthCare Partners Inc.董事。他是国家质量论坛(一家私人非营利公共福利公司,它的建立是为了促进卫生保健质量衡量和报告的标准化)董事会成员及前任董事会主席。
William L. Roper has been one of our directors since May 2001. In January 2019 Dr. Roper became interim president of the University of North Carolina System, North Carolina's system of public higher education. Prior to that, Dr. Roper was chief executive officer of the University of North Carolina “UNC” Health Care System, dean of the UNC School of Medicine and vice chancellor for medical affairs of UNC since March 2004. Dr. Roper has also served on the board of directors of Cigna Corporation, a health services corporation, since December 2018. Dr. Roper also continues to serve as a professor of health policy and administration in the UNC School of Public Health and a professor of pediatrics and of social medicine in the UNC School of Medicine. From 1997 until March 2004 he was dean of the UNC School of Public Health. Before joining UNC in 1997 Dr. Roper served as senior vice president of Prudential Health Care. He also served as director of the Centers for Disease Control and Prevention from 1990 to 1993 on the senior White House staff in 1989 and 1990 and as the administrator of Centers for Medicare & Medicaid Services from 1986 to 1989. Dr. Roper was a member of and is the immediate past chairman of the board of the National Quality Forum, a non-profit organization that aims to improve the quality of healthcare. From December 2007 to November 2011 Dr. Roper served on the board of Medco Health Solutions, Inc., a pharmacy benefits management company, and from November 2011 until December 2018 served on the board of its successor company, Express Scripts Holding Company.
William J. DeLaney

William J. DeLaney, 2011年9月被任命为快捷药方公司董事,自2009年3月起任西斯科公司(食品营销和分销公司)首席执行官,一直到现在。2010年3月担任西斯科公司总裁。1987年他开始在西斯科任职,并担任各种不同职位。2007年7月他成为西斯科公司行政副总裁和首席财务官,直到2009年10月才退下。自2009年1月他就是西斯科公司的董事会成员。 DeLaney先生于2009年至2017年担任Sysco的董事。他获得了圣母大学的学士学位和宾夕法尼亚大学沃顿商学院研究生院的工商管理硕士学位。


William J. Delaney,served as Chief Executive Officer of Sysco Corporation (Sysco), a food marketing and distribution company, from March 2009 until his retirement in December 2017. Previously, Mr. DeLaney served as President of Sysco from March 2010 to January 2016, served as Executive Vice President and Chief Financial Officer from July 2007 to October 2009, and held multiple corporate and operating positions of increasing responsibility throughout his 29-year career with Sysco.In addition to his corporate work, Mr. DeLaney previously served as an active member of his community through his involvement with the Center for Houston's Future and the Greater Houston Partnership.MBA, University of Pennsylvania,Wharton Graduate Division.BBA, University of Notre Dame.
William J. DeLaney, 2011年9月被任命为快捷药方公司董事,自2009年3月起任西斯科公司(食品营销和分销公司)首席执行官,一直到现在。2010年3月担任西斯科公司总裁。1987年他开始在西斯科任职,并担任各种不同职位。2007年7月他成为西斯科公司行政副总裁和首席财务官,直到2009年10月才退下。自2009年1月他就是西斯科公司的董事会成员。 DeLaney先生于2009年至2017年担任Sysco的董事。他获得了圣母大学的学士学位和宾夕法尼亚大学沃顿商学院研究生院的工商管理硕士学位。
William J. Delaney,served as Chief Executive Officer of Sysco Corporation (Sysco), a food marketing and distribution company, from March 2009 until his retirement in December 2017. Previously, Mr. DeLaney served as President of Sysco from March 2010 to January 2016, served as Executive Vice President and Chief Financial Officer from July 2007 to October 2009, and held multiple corporate and operating positions of increasing responsibility throughout his 29-year career with Sysco.In addition to his corporate work, Mr. DeLaney previously served as an active member of his community through his involvement with the Center for Houston's Future and the Greater Houston Partnership.MBA, University of Pennsylvania,Wharton Graduate Division.BBA, University of Notre Dame.
Nicholas J. LaHowchic

Nicholas J. LaHowchic, 2001年7月被任命为快捷药方董事。现任Diannic有限责任公司(一家管理咨询公司)总裁兼首席执行官,2007年才退下。先前,曾与1997年10月起担任有限物流服务公司总裁兼首席执行官,从2004年4月到2007年2月担任有限品牌责任有限公司(一个服装零售公司,LLS公司的前身)执行副总裁。LLS专为零售商(包括有限品牌公司)提供供应链、合规和采购服务。曾任推进汽车零部件有限公司董事。


Nicholas J. LaHowchic was elected a director of Express Scripts in July 2001. Mr. LaHowchic is currently President and Chief Executive Officer of Diannic, LLC, a management consulting firm, and has served in this capacity since February 2007. Previously, he served as President and Chief Executive Officer of Limited Logistics Services, Inc. from October 1997 and as Executive Vice President of Lbrands, Inc. previously Limited Brands, Inc., a retail apparel, personal care and beauty products company from April 2004 until his retirement in February 2007. As Executive Vice President of Lbrands, Inc., Mr. LaHowchic had responsibility for company-wide Information Technology Services and co-lead with Vice-Chairman enterprise ERP Transformation Initiative. Limited Logistics Services, Inc. provides supply chain, compliance and procurement services to retailers including Lbrands, Inc. Previously Mr. LaHowchic also served as President, BD Supply Chain Services through October 1997 for Becton, Dickinson and Company, which develops, manufactures and sells medical devices, instrument systems and reagents worldwide. Mr. LaHowchic currently serves as director of a privately held company and charitable organization and previously served as a director of Advance Auto Parts, Inc.
Nicholas J. LaHowchic, 2001年7月被任命为快捷药方董事。现任Diannic有限责任公司(一家管理咨询公司)总裁兼首席执行官,2007年才退下。先前,曾与1997年10月起担任有限物流服务公司总裁兼首席执行官,从2004年4月到2007年2月担任有限品牌责任有限公司(一个服装零售公司,LLS公司的前身)执行副总裁。LLS专为零售商(包括有限品牌公司)提供供应链、合规和采购服务。曾任推进汽车零部件有限公司董事。
Nicholas J. LaHowchic was elected a director of Express Scripts in July 2001. Mr. LaHowchic is currently President and Chief Executive Officer of Diannic, LLC, a management consulting firm, and has served in this capacity since February 2007. Previously, he served as President and Chief Executive Officer of Limited Logistics Services, Inc. from October 1997 and as Executive Vice President of Lbrands, Inc. previously Limited Brands, Inc., a retail apparel, personal care and beauty products company from April 2004 until his retirement in February 2007. As Executive Vice President of Lbrands, Inc., Mr. LaHowchic had responsibility for company-wide Information Technology Services and co-lead with Vice-Chairman enterprise ERP Transformation Initiative. Limited Logistics Services, Inc. provides supply chain, compliance and procurement services to retailers including Lbrands, Inc. Previously Mr. LaHowchic also served as President, BD Supply Chain Services through October 1997 for Becton, Dickinson and Company, which develops, manufactures and sells medical devices, instrument systems and reagents worldwide. Mr. LaHowchic currently serves as director of a privately held company and charitable organization and previously served as a director of Advance Auto Parts, Inc.
Roderick A. Palmore

Roderick A. Palmore,加入通用磨坊公司,负责全球制造商的食品产品和营销,并在2008年2月担任为执行副总裁,总法律顾问,首席合规与风险管理主任和秘书。从1996年开始直到2008年,他为Sara Lee公司担任领导角色负责各种法律工作。他最终成为执行副总裁,总法律顾问兼秘书。在1996年之前,他曾在美国司法部的部门工作和私人执业。


Roderick A. Palmore,is Senior Counsel at Dentons where he advises public and private corporations and their leadership suites on risk management and governance issues across practices and industry sectors. Mr. Palmore retired from his position as Executive Vice President, General Counsel and Chief Compliance and Risk Management Officer of General Mills, Inc. in February 2015 and has served on the Board of Cboe Global Markets since Cboe Global Markets, Inc. initial public offering in 2010 and of Cboe Options from 2000 to 2017. Prior to joining General Mills in February 2008, he served as Executive Vice President and General Counsel of Sara Lee Corporation. Before joining Sara Lee, Mr. Palmore served in the U.S. Attorney's Office in Chicago and in private practice. Mr. Palmore is currently a member of the board of directors of publicly traded company The Goodyear Tire & Rubber Company and has previously served as a member of the boards of directors of Express Scripts Holding Company, formerly a publicly traded company, Nuveen Investments, Inc. and the United Way of Metropolitan Chicago. Mr. Palmore holds a B.A. degree in Economics from Yale University and a J.D. degree from the University of Chicago Law School.
Roderick A. Palmore,加入通用磨坊公司,负责全球制造商的食品产品和营销,并在2008年2月担任为执行副总裁,总法律顾问,首席合规与风险管理主任和秘书。从1996年开始直到2008年,他为Sara Lee公司担任领导角色负责各种法律工作。他最终成为执行副总裁,总法律顾问兼秘书。在1996年之前,他曾在美国司法部的部门工作和私人执业。
Roderick A. Palmore,is Senior Counsel at Dentons where he advises public and private corporations and their leadership suites on risk management and governance issues across practices and industry sectors. Mr. Palmore retired from his position as Executive Vice President, General Counsel and Chief Compliance and Risk Management Officer of General Mills, Inc. in February 2015 and has served on the Board of Cboe Global Markets since Cboe Global Markets, Inc. initial public offering in 2010 and of Cboe Options from 2000 to 2017. Prior to joining General Mills in February 2008, he served as Executive Vice President and General Counsel of Sara Lee Corporation. Before joining Sara Lee, Mr. Palmore served in the U.S. Attorney's Office in Chicago and in private practice. Mr. Palmore is currently a member of the board of directors of publicly traded company The Goodyear Tire & Rubber Company and has previously served as a member of the boards of directors of Express Scripts Holding Company, formerly a publicly traded company, Nuveen Investments, Inc. and the United Way of Metropolitan Chicago. Mr. Palmore holds a B.A. degree in Economics from Yale University and a J.D. degree from the University of Chicago Law School.

高管简历

中英对照 |  中文 |  英文
Timothy Wentworth

Timothy Wentworth , 2014年2月被任命为公司总裁。从2012年4月到2014年2月,担任销售与客户管理部门高级副总裁。2012年4月快捷药方公司与美可保健公司合并,他于此时加入快捷药方公司。在美可保健公司,他从2008年10月到2012年4月担任全国重要客户集团总裁;2006年3月到2008年10月担任美可保健的附属子公司Accredo健康集团首席执行光;2003年8月到2006年3月担任全国客户集团总裁。


Timothy Wentworth was elected a director of Express Scripts in June 2015. He was elected President of the Company in February 2014 and assumed the role of Chief Executive Officer on May 4 2016. Mr. Wentworth previously served as Senior Vice President and President, Sales and Account Management from April 2012 to February 2014. Mr. Wentworth joined Express Scripts when the Company merged with Medco in April 2012. At Medco, he served as Group President, National and Key Accounts from October 2008 to April 2012 as Chief Executive Officer of Medco’s Accredo Health Group subsidiary from March 2006 to October 2008 and as Group President-National Accounts from August 2003 to March 2006.
Timothy Wentworth , 2014年2月被任命为公司总裁。从2012年4月到2014年2月,担任销售与客户管理部门高级副总裁。2012年4月快捷药方公司与美可保健公司合并,他于此时加入快捷药方公司。在美可保健公司,他从2008年10月到2012年4月担任全国重要客户集团总裁;2006年3月到2008年10月担任美可保健的附属子公司Accredo健康集团首席执行光;2003年8月到2006年3月担任全国客户集团总裁。
Timothy Wentworth was elected a director of Express Scripts in June 2015. He was elected President of the Company in February 2014 and assumed the role of Chief Executive Officer on May 4 2016. Mr. Wentworth previously served as Senior Vice President and President, Sales and Account Management from April 2012 to February 2014. Mr. Wentworth joined Express Scripts when the Company merged with Medco in April 2012. At Medco, he served as Group President, National and Key Accounts from October 2008 to April 2012 as Chief Executive Officer of Medco’s Accredo Health Group subsidiary from March 2006 to October 2008 and as Group President-National Accounts from August 2003 to March 2006.
Neal Sample

Neal Sample,2014年9月以来成为Enterprise Growth总裁。之前,2012年4月以来,他一直是Enterprise Growth 执行副总裁,首席信息官和首席营销技术专家。Sample先生从eBay加入American Express,2011年5月到2012年4月,在eBay担任 X.commerce,eBay的开放开发和商务平台首席技术官。之前,2010年9月到2011年5月,他是eBay的架构和平台产品副总裁。之前,2008年到2010年,他是雅虎副总裁。


Neal Sample was named Senior Vice President and Chief Information Officer of the Company in February 2016. Prior to joining Express Scripts, Dr. Sample served as President, Enterprise Growth at American Express, a global services, payments and travel company, from August 2014 to February 2016 as Chief Information Officer, Enterprise Growth at American Express from April 2012 to August 2014 as Chief Technology Officer, Commerce from May 2011 to April 2012 and as Vice President, Architecture, Technology Product Management at eBay from September 2010 to May 2011. He also served in various roles of increasing responsibility at Yahoo! from 2004 to 2010.
Neal Sample,2014年9月以来成为Enterprise Growth总裁。之前,2012年4月以来,他一直是Enterprise Growth 执行副总裁,首席信息官和首席营销技术专家。Sample先生从eBay加入American Express,2011年5月到2012年4月,在eBay担任 X.commerce,eBay的开放开发和商务平台首席技术官。之前,2010年9月到2011年5月,他是eBay的架构和平台产品副总裁。之前,2008年到2010年,他是雅虎副总裁。
Neal Sample was named Senior Vice President and Chief Information Officer of the Company in February 2016. Prior to joining Express Scripts, Dr. Sample served as President, Enterprise Growth at American Express, a global services, payments and travel company, from August 2014 to February 2016 as Chief Information Officer, Enterprise Growth at American Express from April 2012 to August 2014 as Chief Technology Officer, Commerce from May 2011 to April 2012 and as Vice President, Architecture, Technology Product Management at eBay from September 2010 to May 2011. He also served in various roles of increasing responsibility at Yahoo! from 2004 to 2010.
David Queller

David Queller,2014年7月以来,他曾担任我们的高级销售副总裁、会计经理。加入Express Scripts公司之前,他曾担任Aetna公司的多种高级领导职务,包括高级副总裁,负责国民核算(2013年1月至2014年6月)、多个国家地区的总裁(从2005年5月到2013年1月)。他于2000年10月加入Aetna公司。


David Queller was named Senior Vice President, Sales and Account Management in July 2014. Prior to joining Express Scripts, he served in a number of senior leadership positions at Aetna, Inc., a healthcare benefits company, including Senior Vice President, National Accounts from January 2013 to June 2014 and President of various national regions from May 2005 to January 2013. Mr. Queller joined Aetna Inc. in October 2000.
David Queller,2014年7月以来,他曾担任我们的高级销售副总裁、会计经理。加入Express Scripts公司之前,他曾担任Aetna公司的多种高级领导职务,包括高级副总裁,负责国民核算(2013年1月至2014年6月)、多个国家地区的总裁(从2005年5月到2013年1月)。他于2000年10月加入Aetna公司。
David Queller was named Senior Vice President, Sales and Account Management in July 2014. Prior to joining Express Scripts, he served in a number of senior leadership positions at Aetna, Inc., a healthcare benefits company, including Senior Vice President, National Accounts from January 2013 to June 2014 and President of various national regions from May 2005 to January 2013. Mr. Queller joined Aetna Inc. in October 2000.
Eric Slusser

Eric Slusser,他于2015年9月被任命为公司的执行副总裁兼首席财务官。加入Express Scripts公司之前,他曾担任Gentiva Health Services公司的执行副总裁、首席财务官兼财务主管(从2010年5月到2015年2月),以及高级财务副总裁(从2009年10月到2010年5月)。他此前也曾担任Centene Corporation的多种高级职务,包括执行副总裁,负责国际发展(从2009年5月到2009年10月)、执行副总裁兼首席财务官(从2007年7月到2009年5月)、财务主管(从2008年2月到2009年7月)。加入Centene Corporation之前,他曾担任Cardinal Health公司的财务执行副总裁、首席会计官和总会计师(2006年至2007年)。


Eric Slusser was named Executive Vice President and Chief Financial Officer of the Company in September 2015. Prior to joining Express Scripts, Mr. Slusser served as Executive Vice President, Chief Financial Officer and Treasurer of Gentiva Health Services, Inc., a provider of home healthcare services, from May 2010 to February 2015 and as Senior Vice President, Finance from October 2009 to May 2010. Mr. Slusser also previously served in various senior roles at Centene Corporation, including Executive Vice President, International Development from May 2009 to October 2009 Executive Vice President and Chief Financial Officer from July 2007 to May 2009 and Treasurer from February 2008 to July 2009. Prior to joining Centene Corporation, Mr. Slusser served as Executive Vice President, Finance, Chief Accounting Officer and Controller of Cardinal Health, Inc. from 2006 to 2007.
Eric Slusser,他于2015年9月被任命为公司的执行副总裁兼首席财务官。加入Express Scripts公司之前,他曾担任Gentiva Health Services公司的执行副总裁、首席财务官兼财务主管(从2010年5月到2015年2月),以及高级财务副总裁(从2009年10月到2010年5月)。他此前也曾担任Centene Corporation的多种高级职务,包括执行副总裁,负责国际发展(从2009年5月到2009年10月)、执行副总裁兼首席财务官(从2007年7月到2009年5月)、财务主管(从2008年2月到2009年7月)。加入Centene Corporation之前,他曾担任Cardinal Health公司的财务执行副总裁、首席会计官和总会计师(2006年至2007年)。
Eric Slusser was named Executive Vice President and Chief Financial Officer of the Company in September 2015. Prior to joining Express Scripts, Mr. Slusser served as Executive Vice President, Chief Financial Officer and Treasurer of Gentiva Health Services, Inc., a provider of home healthcare services, from May 2010 to February 2015 and as Senior Vice President, Finance from October 2009 to May 2010. Mr. Slusser also previously served in various senior roles at Centene Corporation, including Executive Vice President, International Development from May 2009 to October 2009 Executive Vice President and Chief Financial Officer from July 2007 to May 2009 and Treasurer from February 2008 to July 2009. Prior to joining Centene Corporation, Mr. Slusser served as Executive Vice President, Finance, Chief Accounting Officer and Controller of Cardinal Health, Inc. from 2006 to 2007.
Martin Akins

Martin Akins,他于2013年10月被任命为高级副总裁兼法律总顾问,也曾于担任公司的公司秘书(2013年5月以来)。他也曾担任副总裁兼副法律总顾问(从2010年2月到2015年10月),以及副总裁兼副法律总顾问(从2008年12月到2010年2月)。他于2001年2月加入公司,担任助理总法律顾问。加入Express Scripts公司之前,他曾担任Polsinelli PC的股东。


Martin Akins was named Senior Vice President and General Counsel in October 2015 and has served as Corporate Secretary since May 2013. Mr. Akins also served as Vice President and Deputy General Counsel from February 2010 to October 2015 and as Vice President and Associate General Counsel from December 2008 to February 2010. Mr. Akins joined the Company in February 2001 as Associate General Counsel. Prior to joining Express Scripts, Mr. Akins was a Shareholder at Polsinelli PC.
Martin Akins,他于2013年10月被任命为高级副总裁兼法律总顾问,也曾于担任公司的公司秘书(2013年5月以来)。他也曾担任副总裁兼副法律总顾问(从2010年2月到2015年10月),以及副总裁兼副法律总顾问(从2008年12月到2010年2月)。他于2001年2月加入公司,担任助理总法律顾问。加入Express Scripts公司之前,他曾担任Polsinelli PC的股东。
Martin Akins was named Senior Vice President and General Counsel in October 2015 and has served as Corporate Secretary since May 2013. Mr. Akins also served as Vice President and Deputy General Counsel from February 2010 to October 2015 and as Vice President and Associate General Counsel from December 2008 to February 2010. Mr. Akins joined the Company in February 2001 as Associate General Counsel. Prior to joining Express Scripts, Mr. Akins was a Shareholder at Polsinelli PC.
Phyllis Anderson

Phyllis Anderson,她于2013年12月被任命为公司的首席营销官,也曾担任高级副总裁(2015年10月以来)。加入Express Scripts公司之前,她曾担任Humana Insurance Company的营销副总裁(2005年3月至2013年10月)。她也曾担任Bank of America的副总裁,负责战略计划—消费者房地产,以及Duke Energy Corporation的市场品牌和战略董事。


Phyllis Anderson was named the Company’s Chief Marketing Officer in December 2013 and has also served as a Senior Vice President since October 2015. Prior to joining Express Scripts, Ms. Anderson served as Vice President, Marketing at Humana Insurance Company from March 2005 to October 2013. Ms. Anderson also served as Vice President, Strategic Initiatives - Consumer Real Estate at Bank of America and Director, Market Brand and Strategy at Duke Energy Corporation.
Phyllis Anderson,她于2013年12月被任命为公司的首席营销官,也曾担任高级副总裁(2015年10月以来)。加入Express Scripts公司之前,她曾担任Humana Insurance Company的营销副总裁(2005年3月至2013年10月)。她也曾担任Bank of America的副总裁,负责战略计划—消费者房地产,以及Duke Energy Corporation的市场品牌和战略董事。
Phyllis Anderson was named the Company’s Chief Marketing Officer in December 2013 and has also served as a Senior Vice President since October 2015. Prior to joining Express Scripts, Ms. Anderson served as Vice President, Marketing at Humana Insurance Company from March 2005 to October 2013. Ms. Anderson also served as Vice President, Strategic Initiatives - Consumer Real Estate at Bank of America and Director, Market Brand and Strategy at Duke Energy Corporation.
Christopher McGinnis

Christopher McGinnis,他于2015年9月被任命为副总裁、首席会计官和总会计师。此前,他曾担任财务和投资者关系副总裁(从2014年8月到2015年8月)、法律和业务开发的副总裁(从2012年4月到2014年7月)、助理总法律顾问(从2010年4月到2012年4月)。2008年3月加入Express Scripts公司之前,他曾担任American Water Works Company的多种法律和商业开发职务。


Christopher McGinnis was named Vice President, Chief Accounting Officer, and Controller in September 2015. Previously, Mr. McGinnis served as Vice President, Finance and Investor Relations from August 2014 to August 2015 as Vice President, Legal and Business Development from April 2012 to July 2014 and as Assistant General Counsel from April 2010 to April 2012. Prior to joining Express Scripts in March 2008 Mr. McGinnis held various accounting, finance, legal and business development roles.
Christopher McGinnis,他于2015年9月被任命为副总裁、首席会计官和总会计师。此前,他曾担任财务和投资者关系副总裁(从2014年8月到2015年8月)、法律和业务开发的副总裁(从2012年4月到2014年7月)、助理总法律顾问(从2010年4月到2012年4月)。2008年3月加入Express Scripts公司之前,他曾担任American Water Works Company的多种法律和商业开发职务。
Christopher McGinnis was named Vice President, Chief Accounting Officer, and Controller in September 2015. Previously, Mr. McGinnis served as Vice President, Finance and Investor Relations from August 2014 to August 2015 as Vice President, Legal and Business Development from April 2012 to July 2014 and as Assistant General Counsel from April 2010 to April 2012. Prior to joining Express Scripts in March 2008 Mr. McGinnis held various accounting, finance, legal and business development roles.
Everett Neville

Everett Neville,2021年1月开始担任信诺保险集团公司执行副总裁,战略和业务发展;从2020年1月到2021年1月,负责价值创造和解决方案的高级副总裁;2018年12月至2020年1月任首席价值官;2018年1月至2018年12月担任Express Scripts战略、供应链和专业执行副总裁;2016年11月至2018年1月,担任战略、供应链和专业高级副总裁;2015年3月至2016年11月任供应链高级副总裁;2009年3月至2015年3月担任制药战略和合同副总裁。他于2015年3月被任命为快捷药方公司高级副总裁,负责供应链。加入Express Scripts公司之前,他曾担任多种临床职务,包括医院和护理管理,作为福利顾问、药剂师和药房董事。


Everett Neville,Executive Vice President, Solutions and Corporate Development of The Cigna Group beginning September 2022; Executive Vice President, Strategy, Corporate Development & Solutions from October 2021 to September 2022; Executive Vice President, Strategy and Business Development from January 2021 to October 2021; Senior Vice President, Value Creation and Solutions from January 2020 until January 2021; Chief Value Officer from December 2018 until January 2020; Executive Vice President, Strategy, Supply Chain & Specialty, Express Scripts from January 2018 until December 2018; Senior Vice President, Strategy, Supply Chain & Specialty from November 2016 until January 2018; and Senior Vice President, Supply Chain from March 2015 until November 2016.
Everett Neville,2021年1月开始担任信诺保险集团公司执行副总裁,战略和业务发展;从2020年1月到2021年1月,负责价值创造和解决方案的高级副总裁;2018年12月至2020年1月任首席价值官;2018年1月至2018年12月担任Express Scripts战略、供应链和专业执行副总裁;2016年11月至2018年1月,担任战略、供应链和专业高级副总裁;2015年3月至2016年11月任供应链高级副总裁;2009年3月至2015年3月担任制药战略和合同副总裁。他于2015年3月被任命为快捷药方公司高级副总裁,负责供应链。加入Express Scripts公司之前,他曾担任多种临床职务,包括医院和护理管理,作为福利顾问、药剂师和药房董事。
Everett Neville,Executive Vice President, Solutions and Corporate Development of The Cigna Group beginning September 2022; Executive Vice President, Strategy, Corporate Development & Solutions from October 2021 to September 2022; Executive Vice President, Strategy and Business Development from January 2021 to October 2021; Senior Vice President, Value Creation and Solutions from January 2020 until January 2021; Chief Value Officer from December 2018 until January 2020; Executive Vice President, Strategy, Supply Chain & Specialty, Express Scripts from January 2018 until December 2018; Senior Vice President, Strategy, Supply Chain & Specialty from November 2016 until January 2018; and Senior Vice President, Supply Chain from March 2015 until November 2016.
Christine Houston

Christine Houston, 2014年2月被任命为运营部高级副总裁。从2012年2月到2014年2月,担任制药和零售部门高级副总裁;2009年1月到2012年2月担任运营部副总裁和总经理的职位。1997年加入公司,并在信息科技和运营部门担任多个领导职位。


Christine Houston was named Executive Vice President and Chief Operations Officer in December 2016 and previously served as Senior Vice President, Operations from February 2014 to December 2016. From February 2012 to February 2014 she served as Senior Vice President, Pharma and Retail Relations and from January 2009 to February 2012 she served as Vice President/General Manager, Operations. Ms. Houston joined Express Scripts in September 1997 and has served in various leadership positions in Information Technology and Operations.
Christine Houston, 2014年2月被任命为运营部高级副总裁。从2012年2月到2014年2月,担任制药和零售部门高级副总裁;2009年1月到2012年2月担任运营部副总裁和总经理的职位。1997年加入公司,并在信息科技和运营部门担任多个领导职位。
Christine Houston was named Executive Vice President and Chief Operations Officer in December 2016 and previously served as Senior Vice President, Operations from February 2014 to December 2016. From February 2012 to February 2014 she served as Senior Vice President, Pharma and Retail Relations and from January 2009 to February 2012 she served as Vice President/General Manager, Operations. Ms. Houston joined Express Scripts in September 1997 and has served in various leadership positions in Information Technology and Operations.
Steven Miller

Steven Miller, 2007年10月被任命为高级副总裁兼首席医务官。2005年4月加入快捷药方担任产品研发副总裁。


Steven Miller was named Senior Vice President and Chief Medical Officer in October 2007. Dr. Miller joined Express Scripts in April 2005 as Vice President, Research and Product.
Steven Miller, 2007年10月被任命为高级副总裁兼首席医务官。2005年4月加入快捷药方担任产品研发副总裁。
Steven Miller was named Senior Vice President and Chief Medical Officer in October 2007. Dr. Miller joined Express Scripts in April 2005 as Vice President, Research and Product.
Glen Stettin

Glen Stettin.Dr., 2012年4月被任命为临床研究和新解决办法部门高级副总裁。2010年12月到2012年4月在美可保健公司担任高级副总裁兼首席医务官,并在2003年7月成为高级副总裁。2010年4月美可保健公司和快捷药方合并,他加入快捷药方公司。自1995年加入美可保健之后,在多个职能领域担任领导职位,包括产品、科技、临床和运营。


Glen Stettin,has served on Medavail Holdings, Inc. board of directors since November 2020. Dr. Stettin previously served on MedAvail Subsidiary's board of directors from May 2018 to February 2022. Dr. Stettin currently serves as Senior VP and Chief Innovation Officer at Evernorth which succeeded Express Scripts Holding Co., a subsidiary of Cigna Corporation, where he has held various leadership positions since 2012. Prior to Express Scripts, Dr. Stettin served in leadership roles in several functional areas, including product, technology, clinical and operations at Medco Health Solutions, Inc. from 1995 to 2012. Dr. Stettin completed his residency in internal medicine at the University of California, San Francisco, where he also served as medical chief resident and assistant chief of the medical service, Moffitt Hospital, and was a fellow in cardiology and Robert Wood Johnson Clinical Scholar at UCSF/Stanford. He received a B.A. in Premedical Sciences from Lehigh University and an M.D. from the Medical College of Pennsylvania.
Glen Stettin.Dr., 2012年4月被任命为临床研究和新解决办法部门高级副总裁。2010年12月到2012年4月在美可保健公司担任高级副总裁兼首席医务官,并在2003年7月成为高级副总裁。2010年4月美可保健公司和快捷药方合并,他加入快捷药方公司。自1995年加入美可保健之后,在多个职能领域担任领导职位,包括产品、科技、临床和运营。
Glen Stettin,has served on Medavail Holdings, Inc. board of directors since November 2020. Dr. Stettin previously served on MedAvail Subsidiary's board of directors from May 2018 to February 2022. Dr. Stettin currently serves as Senior VP and Chief Innovation Officer at Evernorth which succeeded Express Scripts Holding Co., a subsidiary of Cigna Corporation, where he has held various leadership positions since 2012. Prior to Express Scripts, Dr. Stettin served in leadership roles in several functional areas, including product, technology, clinical and operations at Medco Health Solutions, Inc. from 1995 to 2012. Dr. Stettin completed his residency in internal medicine at the University of California, San Francisco, where he also served as medical chief resident and assistant chief of the medical service, Moffitt Hospital, and was a fellow in cardiology and Robert Wood Johnson Clinical Scholar at UCSF/Stanford. He received a B.A. in Premedical Sciences from Lehigh University and an M.D. from the Medical College of Pennsylvania.
Sara Wade

Sara Wade, 2010年被任命为高级副总裁兼首席人力资源官。在此之前,她曾于2009年6月到2010年12月担任公司薪酬与福利部门副总裁。之前她曾任职于可口可乐公司,2008年4月至2009年6月担任薪酬与福利部门公司副总裁;2007年11月到2008年4月担任爱国者煤炭公司人力转高级副总裁。


Sara Wadewas named Senior Vice President and Chief Human Resources Officer in December 2010 and previously served as Vice President, Compensation and Benefits from June 2009 to December 2010. Prior to joining Express Scripts, she served at Coca Cola Enterprises as Corporate Vice President, Compensation and Benefits from April 2008 to June 2009 and at Patriot Coal Corporation as Senior Vice President, Human Resources from November 2007 to April 2008.
Sara Wade, 2010年被任命为高级副总裁兼首席人力资源官。在此之前,她曾于2009年6月到2010年12月担任公司薪酬与福利部门副总裁。之前她曾任职于可口可乐公司,2008年4月至2009年6月担任薪酬与福利部门公司副总裁;2007年11月到2008年4月担任爱国者煤炭公司人力转高级副总裁。
Sara Wadewas named Senior Vice President and Chief Human Resources Officer in December 2010 and previously served as Vice President, Compensation and Benefits from June 2009 to December 2010. Prior to joining Express Scripts, she served at Coca Cola Enterprises as Corporate Vice President, Compensation and Benefits from April 2008 to June 2009 and at Patriot Coal Corporation as Senior Vice President, Human Resources from November 2007 to April 2008.